1 Liu X,Cheng Y,Sheng W,et al.Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach[J].Am J Surg Pathol,2010,34(10):1465-1471. 2 Kumashiro Y,Yao T,Aishima S,et al.Hepatoid adenocarcinoma of the stomach:histogenesis and progression in association with intestinal phenotype[J].Hum Pathol,2007,38(6):857-863. 3 侍孝红,王前玉,陈焰,等.5例胃肝样腺癌临床病理分析[J].现代肿瘤医学,2010,18(10):2012-2014. 4 Ishikura H,Fukasawa Y,Ogasawara K,et al.An AFP-producing gastric carcinoma with features of hepatic differentiation.A case report[J].Cancer,1985,56(4):840-848. 5 Liu XM,Chen GQ,Li SL,et al.Hepatoid adenocarcinoma of the stomach:A case report and literature review[J].Exp Ther Med,2015,9(6):2133-2136. 6 Takeyama H,Sawai H,Wakasugi T,et al.Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases[J].World J Surg Oncol,2007,5(1):1-5. 7 Ye MF,Tao F,Liu F,et al.Hepatoid adenocarcinoma of the stomach:a report of three cases[J].World J Gastroenterol,2013,19(27):4437-4442. 8 贾静,陈剑,王华,等.胃肝样腺癌临床病理、免疫表型及预后分析[J].临床与实验病理学杂志,2014,10(4):443-446. 9 李楠,冯振中,谷从友,等.胃肝样腺癌的临床病理特征[J].中国组织化学与细胞化学杂志,2013,22(1):75-78. 10 周少飞,毛伟征.胃肝样腺癌1例并文献综述[J].临床普外科电子杂志,2013,50(4):46-47. 11 Shimada S,Hayashi N,Marutsuka T,et al.Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases:report of two cases[J].Surg Today,2002,32(12):1075-1080. |